Patients and residence characteristics according to the place of treatment and dialysis technique
| . | . | . | Home dialysis . | |
|---|---|---|---|---|
| . | Home dialysis (n = 7728) . | Facility-based dialysis (n = 71 029) . | Peritoneal dialysis (n = 6898) . | Home haemodialysis (n = 869) . |
| Patient characteristics | ||||
| Age (years); median (Q1–Q3) | 68.9 (55.2–79.9) | 70.9 (60.4–80.2) | 70.4 (58.4–80.9) | 51.8 (41.2–62.7) |
| BMI (kg/m²); median (Q1–Q3) | 25.5 (22.5–29.0) | 25.3 (22.0–29.3) | 25.6 (22.6–29.1) | 25.0 (21.9–28.5) |
| History of RRT (years); median (Q1–Q3) | 0.0 (0.0–2.0) | 1.0 (0.0–4.7) | 0.0 (0.0–1.5) | 4.5 (0.4–16.3) |
| Female; n (%) | 2999 (38.8) | 26 205 (36.9) | 2740 (39.7) | 273 (31.4) |
| Primary renal diagnosis (%) | ||||
| Other | 1140 (14.8) | 10 552 (14.9) | 943 (13.7) | 206 (23.7) |
| Glomerulonephritis | 1286 (16.6) | 8915 (12.6) | 1007 (14.6) | 290 (33.4) |
| Hypertensive nephropathy | 1797 (23.3) | 16 991 (23.9) | 1723 (25) | 81 (9.3) |
| Unknown | 1370 (17.7) | 10 675 (15) | 1287 (18.7) | 86 (9.9) |
| Diabetic nephropathy | 1231 (15.9) | 15 630 (22) | 1172 (17) | 60 (6.9) |
| ADPKD | 534 (6.9) | 4212 (5.9) | 457 (6.6) | 79 (9.1) |
| Pyelonephritis | 328 (4.2) | 3569 (5) | 270 (3.9) | 64 (7.4) |
| Vascular nephropathy | 42 (0.5) | 485 (0.7) | 39 (0.6) | 3 (0.3) |
| Comorbidities; n (%) | ||||
| Diabetes mellitus | 2780 (36.2) | 30 933 (43.8) | 2645 (38.6) | 138 (15.9) |
| Heart failure | 2039 (26.8) | 19 118 (27.3) | 1920 (28.4) | 126 (14.6) |
| Coronary heart disease | 2048 (27) | 20 920 (29.9) | 1904 (28.1) | 149 (17.2) |
| Peripheral vascular disease | 1569 (20.8) | 19 209 (27.6) | 1439 (21.5) | 132 (15.3) |
| Dysrhythmia | 2022 (26.6) | 19 696 (28.1) | 1907 (28.2) | 121 (14) |
| Cerebrovascular disease | 880 (11.6) | 9596 (13.7) | 831 (12.2) | 52 (6) |
| Malignancy | 711 (9.4) | 9165 (13.1) | 616 (9.1) | 99 (11.4) |
| Pulmonary disease | 1104 (14.6) | 12643 (18.1) | 1004 (14.9) | 102 (11.8) |
| Behaviour disorder | 224 (3.1) | 3253 (4.8) | 213 (3.3) | 11 (1.3) |
| Liver disease | 297 (4) | 3652 (5.3) | 257 (3.8) | 40 (4.7) |
| Mobility, n (%) | ||||
| Totally dependent | 336 (4.6) | 4855 (7.1) | 324 (5) | 12 (1.4) |
| Autonomy for transfer | 6350 (86.5) | 53 496 (78.7) | 5575 (85.4) | 813 (95.5) |
| Need help | 655 (8.9) | 9609 (14.1) | 629 (9.6) | 26 (3.1) |
| Distance to dialysis centre (minutes); median (Q1–Q3) | 13.0 (7.0–22.0) | 11.0 (6.0–19.0) | 13.0 (7.0–22.0) | 13.0 (7.0–22.0) |
| Residence characteristics | ||||
| % of housing surface <30 m²; median (Q1–Q3) | 1.8 (0.4–4.9) | 2.6 (0.8–6.3) | 1.8 (0.4–4.9) | 2.3 (0.4–5.6) |
| Income (€/year); median (Q1–Q3) | 21 020 (19 370–23 150) | 20 790 (19 110–23 050) | 21 000 (19 370–23 140) | 21 120 (19 330–23 160) |
| Interdecile ratio income; median (Q1–Q3) | 3.2 (2.9–3.6) | 3.3 (2.9–3.7) | 3.2 (2.9–3.6) | 3.3 (2.9–3.7) |
| % with university degree; median (Q1–Q3) | 24.6 (18.6–32.3) | 25.2 (19.1–33.3) | 24.6 (18.6–32.1) | 25.1 (18.6–32.8) |
| Spatial environment (%) | ||||
| Isolated area | 440 (5.8) | 3261 (4.7) | 387 (5.7) | 56 (6.6) |
| Peri-urban area | 2739 (36.2) | 20 488 (29.4) | 2473 (36.6) | 281 (33.3) |
| Urban centre | 4393 (58) | 45 932 (65.9) | 3905 (57.7) | 508 (60.1) |
| . | . | . | Home dialysis . | |
|---|---|---|---|---|
| . | Home dialysis (n = 7728) . | Facility-based dialysis (n = 71 029) . | Peritoneal dialysis (n = 6898) . | Home haemodialysis (n = 869) . |
| Patient characteristics | ||||
| Age (years); median (Q1–Q3) | 68.9 (55.2–79.9) | 70.9 (60.4–80.2) | 70.4 (58.4–80.9) | 51.8 (41.2–62.7) |
| BMI (kg/m²); median (Q1–Q3) | 25.5 (22.5–29.0) | 25.3 (22.0–29.3) | 25.6 (22.6–29.1) | 25.0 (21.9–28.5) |
| History of RRT (years); median (Q1–Q3) | 0.0 (0.0–2.0) | 1.0 (0.0–4.7) | 0.0 (0.0–1.5) | 4.5 (0.4–16.3) |
| Female; n (%) | 2999 (38.8) | 26 205 (36.9) | 2740 (39.7) | 273 (31.4) |
| Primary renal diagnosis (%) | ||||
| Other | 1140 (14.8) | 10 552 (14.9) | 943 (13.7) | 206 (23.7) |
| Glomerulonephritis | 1286 (16.6) | 8915 (12.6) | 1007 (14.6) | 290 (33.4) |
| Hypertensive nephropathy | 1797 (23.3) | 16 991 (23.9) | 1723 (25) | 81 (9.3) |
| Unknown | 1370 (17.7) | 10 675 (15) | 1287 (18.7) | 86 (9.9) |
| Diabetic nephropathy | 1231 (15.9) | 15 630 (22) | 1172 (17) | 60 (6.9) |
| ADPKD | 534 (6.9) | 4212 (5.9) | 457 (6.6) | 79 (9.1) |
| Pyelonephritis | 328 (4.2) | 3569 (5) | 270 (3.9) | 64 (7.4) |
| Vascular nephropathy | 42 (0.5) | 485 (0.7) | 39 (0.6) | 3 (0.3) |
| Comorbidities; n (%) | ||||
| Diabetes mellitus | 2780 (36.2) | 30 933 (43.8) | 2645 (38.6) | 138 (15.9) |
| Heart failure | 2039 (26.8) | 19 118 (27.3) | 1920 (28.4) | 126 (14.6) |
| Coronary heart disease | 2048 (27) | 20 920 (29.9) | 1904 (28.1) | 149 (17.2) |
| Peripheral vascular disease | 1569 (20.8) | 19 209 (27.6) | 1439 (21.5) | 132 (15.3) |
| Dysrhythmia | 2022 (26.6) | 19 696 (28.1) | 1907 (28.2) | 121 (14) |
| Cerebrovascular disease | 880 (11.6) | 9596 (13.7) | 831 (12.2) | 52 (6) |
| Malignancy | 711 (9.4) | 9165 (13.1) | 616 (9.1) | 99 (11.4) |
| Pulmonary disease | 1104 (14.6) | 12643 (18.1) | 1004 (14.9) | 102 (11.8) |
| Behaviour disorder | 224 (3.1) | 3253 (4.8) | 213 (3.3) | 11 (1.3) |
| Liver disease | 297 (4) | 3652 (5.3) | 257 (3.8) | 40 (4.7) |
| Mobility, n (%) | ||||
| Totally dependent | 336 (4.6) | 4855 (7.1) | 324 (5) | 12 (1.4) |
| Autonomy for transfer | 6350 (86.5) | 53 496 (78.7) | 5575 (85.4) | 813 (95.5) |
| Need help | 655 (8.9) | 9609 (14.1) | 629 (9.6) | 26 (3.1) |
| Distance to dialysis centre (minutes); median (Q1–Q3) | 13.0 (7.0–22.0) | 11.0 (6.0–19.0) | 13.0 (7.0–22.0) | 13.0 (7.0–22.0) |
| Residence characteristics | ||||
| % of housing surface <30 m²; median (Q1–Q3) | 1.8 (0.4–4.9) | 2.6 (0.8–6.3) | 1.8 (0.4–4.9) | 2.3 (0.4–5.6) |
| Income (€/year); median (Q1–Q3) | 21 020 (19 370–23 150) | 20 790 (19 110–23 050) | 21 000 (19 370–23 140) | 21 120 (19 330–23 160) |
| Interdecile ratio income; median (Q1–Q3) | 3.2 (2.9–3.6) | 3.3 (2.9–3.7) | 3.2 (2.9–3.6) | 3.3 (2.9–3.7) |
| % with university degree; median (Q1–Q3) | 24.6 (18.6–32.3) | 25.2 (19.1–33.3) | 24.6 (18.6–32.1) | 25.1 (18.6–32.8) |
| Spatial environment (%) | ||||
| Isolated area | 440 (5.8) | 3261 (4.7) | 387 (5.7) | 56 (6.6) |
| Peri-urban area | 2739 (36.2) | 20 488 (29.4) | 2473 (36.6) | 281 (33.3) |
| Urban centre | 4393 (58) | 45 932 (65.9) | 3905 (57.7) | 508 (60.1) |
RRT, renal replacement therapy; ADPKD, autosomal dominant polycystic kidney disease.
Patients and residence characteristics according to the place of treatment and dialysis technique
| . | . | . | Home dialysis . | |
|---|---|---|---|---|
| . | Home dialysis (n = 7728) . | Facility-based dialysis (n = 71 029) . | Peritoneal dialysis (n = 6898) . | Home haemodialysis (n = 869) . |
| Patient characteristics | ||||
| Age (years); median (Q1–Q3) | 68.9 (55.2–79.9) | 70.9 (60.4–80.2) | 70.4 (58.4–80.9) | 51.8 (41.2–62.7) |
| BMI (kg/m²); median (Q1–Q3) | 25.5 (22.5–29.0) | 25.3 (22.0–29.3) | 25.6 (22.6–29.1) | 25.0 (21.9–28.5) |
| History of RRT (years); median (Q1–Q3) | 0.0 (0.0–2.0) | 1.0 (0.0–4.7) | 0.0 (0.0–1.5) | 4.5 (0.4–16.3) |
| Female; n (%) | 2999 (38.8) | 26 205 (36.9) | 2740 (39.7) | 273 (31.4) |
| Primary renal diagnosis (%) | ||||
| Other | 1140 (14.8) | 10 552 (14.9) | 943 (13.7) | 206 (23.7) |
| Glomerulonephritis | 1286 (16.6) | 8915 (12.6) | 1007 (14.6) | 290 (33.4) |
| Hypertensive nephropathy | 1797 (23.3) | 16 991 (23.9) | 1723 (25) | 81 (9.3) |
| Unknown | 1370 (17.7) | 10 675 (15) | 1287 (18.7) | 86 (9.9) |
| Diabetic nephropathy | 1231 (15.9) | 15 630 (22) | 1172 (17) | 60 (6.9) |
| ADPKD | 534 (6.9) | 4212 (5.9) | 457 (6.6) | 79 (9.1) |
| Pyelonephritis | 328 (4.2) | 3569 (5) | 270 (3.9) | 64 (7.4) |
| Vascular nephropathy | 42 (0.5) | 485 (0.7) | 39 (0.6) | 3 (0.3) |
| Comorbidities; n (%) | ||||
| Diabetes mellitus | 2780 (36.2) | 30 933 (43.8) | 2645 (38.6) | 138 (15.9) |
| Heart failure | 2039 (26.8) | 19 118 (27.3) | 1920 (28.4) | 126 (14.6) |
| Coronary heart disease | 2048 (27) | 20 920 (29.9) | 1904 (28.1) | 149 (17.2) |
| Peripheral vascular disease | 1569 (20.8) | 19 209 (27.6) | 1439 (21.5) | 132 (15.3) |
| Dysrhythmia | 2022 (26.6) | 19 696 (28.1) | 1907 (28.2) | 121 (14) |
| Cerebrovascular disease | 880 (11.6) | 9596 (13.7) | 831 (12.2) | 52 (6) |
| Malignancy | 711 (9.4) | 9165 (13.1) | 616 (9.1) | 99 (11.4) |
| Pulmonary disease | 1104 (14.6) | 12643 (18.1) | 1004 (14.9) | 102 (11.8) |
| Behaviour disorder | 224 (3.1) | 3253 (4.8) | 213 (3.3) | 11 (1.3) |
| Liver disease | 297 (4) | 3652 (5.3) | 257 (3.8) | 40 (4.7) |
| Mobility, n (%) | ||||
| Totally dependent | 336 (4.6) | 4855 (7.1) | 324 (5) | 12 (1.4) |
| Autonomy for transfer | 6350 (86.5) | 53 496 (78.7) | 5575 (85.4) | 813 (95.5) |
| Need help | 655 (8.9) | 9609 (14.1) | 629 (9.6) | 26 (3.1) |
| Distance to dialysis centre (minutes); median (Q1–Q3) | 13.0 (7.0–22.0) | 11.0 (6.0–19.0) | 13.0 (7.0–22.0) | 13.0 (7.0–22.0) |
| Residence characteristics | ||||
| % of housing surface <30 m²; median (Q1–Q3) | 1.8 (0.4–4.9) | 2.6 (0.8–6.3) | 1.8 (0.4–4.9) | 2.3 (0.4–5.6) |
| Income (€/year); median (Q1–Q3) | 21 020 (19 370–23 150) | 20 790 (19 110–23 050) | 21 000 (19 370–23 140) | 21 120 (19 330–23 160) |
| Interdecile ratio income; median (Q1–Q3) | 3.2 (2.9–3.6) | 3.3 (2.9–3.7) | 3.2 (2.9–3.6) | 3.3 (2.9–3.7) |
| % with university degree; median (Q1–Q3) | 24.6 (18.6–32.3) | 25.2 (19.1–33.3) | 24.6 (18.6–32.1) | 25.1 (18.6–32.8) |
| Spatial environment (%) | ||||
| Isolated area | 440 (5.8) | 3261 (4.7) | 387 (5.7) | 56 (6.6) |
| Peri-urban area | 2739 (36.2) | 20 488 (29.4) | 2473 (36.6) | 281 (33.3) |
| Urban centre | 4393 (58) | 45 932 (65.9) | 3905 (57.7) | 508 (60.1) |
| . | . | . | Home dialysis . | |
|---|---|---|---|---|
| . | Home dialysis (n = 7728) . | Facility-based dialysis (n = 71 029) . | Peritoneal dialysis (n = 6898) . | Home haemodialysis (n = 869) . |
| Patient characteristics | ||||
| Age (years); median (Q1–Q3) | 68.9 (55.2–79.9) | 70.9 (60.4–80.2) | 70.4 (58.4–80.9) | 51.8 (41.2–62.7) |
| BMI (kg/m²); median (Q1–Q3) | 25.5 (22.5–29.0) | 25.3 (22.0–29.3) | 25.6 (22.6–29.1) | 25.0 (21.9–28.5) |
| History of RRT (years); median (Q1–Q3) | 0.0 (0.0–2.0) | 1.0 (0.0–4.7) | 0.0 (0.0–1.5) | 4.5 (0.4–16.3) |
| Female; n (%) | 2999 (38.8) | 26 205 (36.9) | 2740 (39.7) | 273 (31.4) |
| Primary renal diagnosis (%) | ||||
| Other | 1140 (14.8) | 10 552 (14.9) | 943 (13.7) | 206 (23.7) |
| Glomerulonephritis | 1286 (16.6) | 8915 (12.6) | 1007 (14.6) | 290 (33.4) |
| Hypertensive nephropathy | 1797 (23.3) | 16 991 (23.9) | 1723 (25) | 81 (9.3) |
| Unknown | 1370 (17.7) | 10 675 (15) | 1287 (18.7) | 86 (9.9) |
| Diabetic nephropathy | 1231 (15.9) | 15 630 (22) | 1172 (17) | 60 (6.9) |
| ADPKD | 534 (6.9) | 4212 (5.9) | 457 (6.6) | 79 (9.1) |
| Pyelonephritis | 328 (4.2) | 3569 (5) | 270 (3.9) | 64 (7.4) |
| Vascular nephropathy | 42 (0.5) | 485 (0.7) | 39 (0.6) | 3 (0.3) |
| Comorbidities; n (%) | ||||
| Diabetes mellitus | 2780 (36.2) | 30 933 (43.8) | 2645 (38.6) | 138 (15.9) |
| Heart failure | 2039 (26.8) | 19 118 (27.3) | 1920 (28.4) | 126 (14.6) |
| Coronary heart disease | 2048 (27) | 20 920 (29.9) | 1904 (28.1) | 149 (17.2) |
| Peripheral vascular disease | 1569 (20.8) | 19 209 (27.6) | 1439 (21.5) | 132 (15.3) |
| Dysrhythmia | 2022 (26.6) | 19 696 (28.1) | 1907 (28.2) | 121 (14) |
| Cerebrovascular disease | 880 (11.6) | 9596 (13.7) | 831 (12.2) | 52 (6) |
| Malignancy | 711 (9.4) | 9165 (13.1) | 616 (9.1) | 99 (11.4) |
| Pulmonary disease | 1104 (14.6) | 12643 (18.1) | 1004 (14.9) | 102 (11.8) |
| Behaviour disorder | 224 (3.1) | 3253 (4.8) | 213 (3.3) | 11 (1.3) |
| Liver disease | 297 (4) | 3652 (5.3) | 257 (3.8) | 40 (4.7) |
| Mobility, n (%) | ||||
| Totally dependent | 336 (4.6) | 4855 (7.1) | 324 (5) | 12 (1.4) |
| Autonomy for transfer | 6350 (86.5) | 53 496 (78.7) | 5575 (85.4) | 813 (95.5) |
| Need help | 655 (8.9) | 9609 (14.1) | 629 (9.6) | 26 (3.1) |
| Distance to dialysis centre (minutes); median (Q1–Q3) | 13.0 (7.0–22.0) | 11.0 (6.0–19.0) | 13.0 (7.0–22.0) | 13.0 (7.0–22.0) |
| Residence characteristics | ||||
| % of housing surface <30 m²; median (Q1–Q3) | 1.8 (0.4–4.9) | 2.6 (0.8–6.3) | 1.8 (0.4–4.9) | 2.3 (0.4–5.6) |
| Income (€/year); median (Q1–Q3) | 21 020 (19 370–23 150) | 20 790 (19 110–23 050) | 21 000 (19 370–23 140) | 21 120 (19 330–23 160) |
| Interdecile ratio income; median (Q1–Q3) | 3.2 (2.9–3.6) | 3.3 (2.9–3.7) | 3.2 (2.9–3.6) | 3.3 (2.9–3.7) |
| % with university degree; median (Q1–Q3) | 24.6 (18.6–32.3) | 25.2 (19.1–33.3) | 24.6 (18.6–32.1) | 25.1 (18.6–32.8) |
| Spatial environment (%) | ||||
| Isolated area | 440 (5.8) | 3261 (4.7) | 387 (5.7) | 56 (6.6) |
| Peri-urban area | 2739 (36.2) | 20 488 (29.4) | 2473 (36.6) | 281 (33.3) |
| Urban centre | 4393 (58) | 45 932 (65.9) | 3905 (57.7) | 508 (60.1) |
RRT, renal replacement therapy; ADPKD, autosomal dominant polycystic kidney disease.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
